|

KN5601 Clinical Trials

1 actively recruiting trial

Pipeline

Early 1: 1

Top Sponsors

  • The Children's Hospital of Zhejiang University School of Medicine1

Indications

  • Connective Tissue Disease-associated Interstitial Lung Disease1
  • Pediatric Rheumatological Condition (i.e., Arthritis, SLE, Kawasaki's Disaese)1
  • Rheumatic Diseases1
  • Systemic Lupus Erythematosus (SLE)1
  • Lupus1

Other1 trial

Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA CAR-NK Cell Injection for the Treatment of Refractory Pediatric Rheumatic Diseases
Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.